References Abu Ahmad N, Armaly Z, Berman S, Jabour A, Aga-Mizrachi S, Mosenego-Ornan E, Avital A (2016) l-Carnitine improves cognitive and renal functions in a rat model of chronic kidney disease
The FDA BPC-157 vote gives inclusion meaningful momentum, and agencies often give their advisory committees considerable weight
When to stop or reconsider GLP-1 therapy Not every Hashimoto's patient should stay on GLP-1 medications indefinitely
doi: 10.1093/jxb/erz330 63 FratelliM.DemolH.PuypeM.CasagrandeS.VillaP.EberiniI.et al
However, emerging research suggests that these drugs may come with an unexpected riskan increased incidence of ischemic optic neuropathy, a condition closely related to ischemic retinopathy
Indeed, GGT1 has been studied in the context of kidney cancer, with pro-tumour and antitumour effects being attributed 54,55,56